Back
CONMED Corp. 10K Form
Sell
43
CNMD
CONMED Corp.
Last Price:
$44.22
Seasonality Move:
11.55%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-25 | 10Q | CNMD/CONMED Corp. Quarterly |
| 2024-02-28 | 10K | CNMD/CONMED Corp. Annual |
| 2023-10-26 | 10Q | CNMD/CONMED Corp. Quarterly |
| 2023-07-27 | 10Q | CNMD/CONMED Corp. Quarterly |
| 2023-04-27 | 10Q | CNMD/CONMED Corp. Quarterly |
| 2023-02-21 | 10K | CNMD/CONMED Corp. Annual |
Receive CNMD News And Ratings
See the #1 stock for the next 7 days that we like better than CNMD
CNMD Financial Statistics
Sales & Book Value
| Annual Sales: | $1.3B |
|---|---|
| Cash Flow: | $48.5M |
| Price / Cash Flow: | 9.24 |
| Annual Sales: | $32.57 |
| Price / Book: | 1.36 |
Profitability
| EPS (TTM): | 2.05940 |
|---|---|
| Net Income (TTM): | $64.1M |
| Gross Margin: | $694.6M |
| Return on Equity: | 6.56% |
| Return on Assets: | 2.77% |
CONMED Corp. Earnings Forecast
Key CONMED Corp. Financial Ratios
-
The Gross Profit Margin over the past 39 years for CNMD is 53.32%.
-
The Selling, General & Administrative Expenses for CNMD have been equal to 36.71% of Gross Profit Margin.
-
The Research & Development expenses have been 4.18% of Revenue.
-
The Interest Expense is 28.17% of Operating Income.
-
The Net Earning history of CNMD is 10.17% of Total Revenues.
-
Per Share Earnings over the last 39 years have been positive in 17 years.
CONMED Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | CNMD |
| CUSIP: | 207410 |
| Website: | conmed.com |
Debt
| Debt-to-Equity Ratio: | 0.85 |
|---|---|
| Current Ratio: | 2.1 |
| Quick Ratio: | 0.84 |
Price-to-Earnings
| Trailing P/E Ratio: | 10.41 |
|---|---|
| Forward P/E Ratio: | 9.24 |
CNMD Technical Analysis vs Fundamental Analysis
Sell
43
CONMED Corp. (CNMD)
is a Sell
Is CONMED Corp. a Buy or a Sell?
-
CONMED Corp. stock is rated a SellThe current CONMED Corp. [CNMD] share price is $44.24. The Score for CNMD is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.